gastroenterology
Hepatology

Professor Nick Shackel: What’s in store for liver disease in 2019?


Point-of-care hepatitis C testing, new combination therapies for liver cancer, and understanding the role of the gut microbiome in fatty liver disease are just some of the promises around liver disease in 2019. With rates of obesity as high as 50-60%...

Point-of-care hepatitis C testing, new combination therapies for liver cancer, and understanding the role of the gut microbiome in fatty...

Read more